Development of Gnosco commercialisation in Australia

Syfte och mål

The project goal was to engage with local Australian healthcare expertise to investigate opportunities and barriers prior to Australia market entry for the Dermicus teledermatology platform. The work has been successful in verifying that Dermicus teledermatology platform can be compliant local requirements for patient data and clinical safety. There is also a better understanding of diagnostic procedures, barriers, stakeholders and health economics. This has been achieved by working in collaboration with the local consultants and engagement with Queensland & New South Wales.

Resultat och förväntade effekter

The main outcome of the work is that it identified a priority dermatology area for further qualification. An additional outcome has been the identification of a number of candidate reference projects and stakeholders in Queensland and New South Wales to develop during future go to market planning. This will enable Gnosco to build a detailed go to market plan in conjunction with a specific local market reference which is vital for the commercial successes of Dermicus in Australia. This project further emphasised the importance of a local reference, as seen for example in the UK NHS.

Upplägg och genomförande

Gnosco and JPC worked collaboratively to create a project plan, specify activities, assign project roles and allocated time for the joint analysis and summary from the project. Early in the research and consultation, it became evident that it would be more fruitful for Gnosco to concentrate its early market entry focus on one area of dermatology, different to the priorities of other Gnosco markets (Sweden and UK). Gnosco and JPC discussed and agreed on a focused approach to the identified domain.